Cargando…
Proposed multidimensional framework for understanding Chagas disease healthcare barriers in the United States
BACKGROUND: Chagas disease (CD) affects over 300,000 people in the United States, but fewer than 1% have been diagnosed and less than 0.3% have received etiological treatment. This is a significant public health concern because untreated CD can produce fatal complications. What factors prevent peopl...
Autores principales: | Forsyth, Colin, Meymandi, Sheba, Moss, Ilan, Cone, Jason, Cohen, Rachel, Batista, Carolina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6762052/ https://www.ncbi.nlm.nih.gov/pubmed/31557155 http://dx.doi.org/10.1371/journal.pntd.0007447 |
Ejemplares similares
-
Treatment of Chagas Disease in the United States
por: Meymandi, Sheba, et al.
Publicado: (2018) -
Prevalence of Chagas Disease Among Family Members of Previously Diagnosed Patients in Los Angeles, California
por: Hernandez, Salvador, et al.
Publicado: (2019) -
Progression of Baseline Electrocardiogram Abnormalities in Chagas Patients Undergoing Antitrypanosomal Treatment
por: Soverow, Jonathan, et al.
Publicado: (2019) -
Prevalence of Chagas Disease in the Latin American–born Population of Los Angeles
por: Meymandi, Sheba K., et al.
Publicado: (2017) -
Safety Profile of Nifurtimox for Treatment of Chagas Disease in the United States
por: Forsyth, Colin J., et al.
Publicado: (2016)